What one share of Cyclerion Therapeutics holds
We focus on building a pipeline of innovative therapeutics to address serious neuropsychiatric disorders with significant unmet medical need. Our current strategic focus is centered on the development of a novel therapeutic approach for neuropsychiatric conditions, with the lead indication being treatment-resistant depression (“TRD”), which we believe represents a substantial clinical and commercial opportunity.
Cyclerion Therapeutics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.49 |
|---|---|
| Profit | −$1.73 |
| Cash and investments | $0.33 |
| Book value | $1.20 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2022 | $0.14 | −$20.28 | $0.00 | −$18.69 | — | $4.80 |
| 2023 | $0.00 | −$2.25 | — | — | — | $4.56 |
| 2024 | $0.79 | −$1.21 | — | — | — | $3.48 |
| 2025 | $0.65 | −$1.11 | — | — | — | $2.38 |
Common questions about Cyclerion Therapeutics
How much does one share of Cyclerion Therapeutics earn?
Over the last 12 months, Cyclerion Therapeutics lost $1.73 for each share on $0.49 of sales.
Does Cyclerion Therapeutics pay a dividend?
Cyclerion Therapeutics didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Cyclerion Therapeutics’s book value per share?
Cyclerion Therapeutics’s book value is $1.20 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Cyclerion Therapeutics have?
Each share of Cyclerion Therapeutics has $0.33 of cash and investments, as of June 30, 2026.
Has Cyclerion Therapeutics bought back shares?
Cyclerion Therapeutics’s share count rose about 46% from 2022 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.